Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Changyanning plus probiotics for antibiotic-associated diarrhea
ChiCTR2400090014Phase 4Recruiting
- Sponsor
- Affiliated Hospital of Hangzhou Normal University
- Start
- Sep 2024
- Countries
- 1
01
Overview
Phase 4, open-label trial of Changyanning in antibiotic-associated diarrhea (AAD) (2 arms), sponsored by Affiliated Hospital of Hangzhou Normal University. Primary endpoints: Gastrointestinal symptom assessment and Gastrointestinal Quality of Life Index. Started Sep 2024; status: recruiting.
02
Drugs
Changyanning
03
Conditions
antibiotic-associated diarrhea (AAD)
Beyond the preview
Go deeper on ChiCTR2400090014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400090014.